WHO ICTRP trial

A Phase IIIb, Multicentre, Open-Label, Randomized, Controlled Study of the…

NL-OMON36625 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting

Key facts

Trial ID NL-OMON36625
Public title A Phase IIIb, Multicentre, Open-Label, Randomized, Controlled Study of the Efficacy, Safety, and Population Pharmacokinetics of Sapropterin Dihydrochloride (Kuvan®) in Phenylketonuria (PKU) Patients <4 Years Old
Scientific title A Phase IIIb, Multicentre, Open-Label, Randomized, Controlled Study of the Efficacy, Safety, and Population Pharmacokinetics of Sapropterin Dihydrochloride (Kuvan®) in Phenylketonuria (PKU) Patients <4 Years Old - SPARK (Safety Paediatric efficAcy phaRmacokinetic with Kuvan®)
Primary sponsor Merck Serono S.A. Geneva
Registry Overview of Medical Research in the Netherlands (NL-OMON)
Recruitment status Not Recruiting
Study type Interventional
Phase 3
Countries Austria;Belgium;Czechia;Germany;Italy;Netherlands ;Turkey
Conditions Phenylketonuria (PKU) Phenylketonuria (PKU);Phenylketonuria (PKU)
Interventions Measuring Phe levels in blood (at the hospital + at home) blood sampling for PopPK BH4 responsiveness test ;Phenylketonuria (PKU)
Registration date Jan 12, 2012
Target size 15
Secondary IDs 2009-015768-33;NCT01376908;NL32785.068.10
Registry page onderzoekmetmensen.nl

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations